Medindia LOGIN REGISTER
Medindia

Gene Therapy Prevents Disorders With Alcohol Exposure in ALDH2 Deficiency, Says Study

by Colleen Fleiss on Feb 14 2020 2:22 AM

A new study has revealed that gene therapy to aldehyde dehydrogenase type 2 (ALDH2) deficiency, a genetic disorder helps prevent the higher risk for cancer of esophagus linked to chronic alcohol exposure.

Gene Therapy Prevents Disorders With Alcohol Exposure in ALDH2 Deficiency, Says Study
Gene therapy to treat aldehyde dehydrogenase type 2 (ALDH2) deficiency helps prevent increased risk for esophageal cancer and osteoporosis linked to chronic alcohol exposure, revealed study.
The study, performed in a mouse model of ALDH2, //is published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Click here to read the full-text article free on the Human Gene Therapy website through March 12, 2020.

Ronald Crystal, Matthew Greenblatt, Katie Stiles, and colleagues from Weill Cornell Medical College, The Rockefeller University, and Hospital for Special Surgery, New York, NY, coauthored the article entitled "Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion." The researchers delivered the ALDH2 gene to two mouse models of ALDH2 deficiency using an adeno-associated virus (AAV) vector. Some of the mice were then given ethanol in their drinking water over a 12-week period.

Compared to the non-ethanol drinking mice, the mice treated with gene therapy who ingested alcohol did not show signs of either the acute abnormalities or the chronic disorders normally associated with ethanol exposure in ALDH2 deficiency.

"This work by Dr. Crystal and his collaborators points to a new potential therapy for individuals with a particular genetic susceptibility to suffer long-term consequences of excessive drinking," says Editor-in-Chief Terence R. Flotte, MD, Celia and Isaac Haidak Professor of Medical Education and Dean, Provost, and Executive Deputy Chancellor, University of Massachusetts Medical School, Worcester, MA.

Source-Eurekalert


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education